Get intelligentvalue.com

Own it today or select a payment plan

Secured by Stripe

Premium Domain Name

intelligentvalue.com

intelligentvalue.com logo

is available for purchase

291 views
Visitors fromUSUS 53%·AUAU 34%·ININ 7%·GBGB 2%·HKHK 1%

Unlock the potential of 'intelligentvalue.com', a premium domain that embodies sophistication and expertise in investment advisory and financial consulting. Perfect for businesses in artificial intelligence solutions, market research, and strategic planning, this memorable domain conveys a strong branding message that resonates with clients seeking innovative and data-driven insights. Elevate your presence in the competitive landscape with a digital identity that signifies intelligence, value, and forward-thinking solutions.

Safe & Secure

Protected transactions with Stripe

Fast Transfer

Domain transferred within 24 hours

Flexible Payments

Interest-free payment plans available

VisaMastercardAmerican ExpressDiscoverDiners ClubJCBApple PayGoogle Pay

FUTRUE Neurosciences Reaches Major Milestone

By: PR Leap
ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.
(PRLeap.com) Gräfelfing (Germany), 03/31/2026: FUTRUE Neurosciences has achieved its first milestone on its mission to become the global leader in modern brain-computer interfaces (BCIs) by 2030. BCIs establish a direct interface between the human brain and digital systems. In the medium term, this technology has the potential to redefine the boundaries of medicine - enabling people with paralysis to walk again, restoring vision to the blind, and allowing those who cannot speak to communicate once more.

With the development of a novel microelectrode array (mikro-ECoG) designed to be placed on the surface of the brain and transmit information directly to specific brain areas, FUTRUE Neurosciences has now completed a key technological step on its journey.

According to founder Dr. Clemens Fischer, the newly developed electrode array is currently the most advanced mikro-ECoG system. Featuring 512 electrodes for targeted stimulation, the system opens up further possibilities for next-generation neural interfaces.

"With our newly developed microelectrode array, we have reached a decisive technological milestone in a very short period of time," said Dr. Clemens Fischer, founder of FUTRUE Neurosciences. "Our goal is to lay the foundation for initial clinical applications later this year."

Looking ahead, Fischer sees brain-computer interfaces not only as a highly promising tool for supporting patients with severe illnesses, but also as a key enabling technology for future forms of human-machine interaction. In his view, BCIs could ultimately allow humans to develop entirely new forms of consciousness and think in ways that are beyond our imagination today.


Press contact
Email: presse@futrue.com
Phone: +49 89 78 79 790 78

GET IN TOUCH

FUTRUE GmbH
+49 89 78 79 790 78

You can see the original version and more on PRLeap here: http://www.prleap.com/pr/310954/futrue-neurosciences-reaches-major-milestone

Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  268.26
+3.20 (1.21%)
AAPL  280.14
+8.79 (3.24%)
AMD  360.54
+6.05 (1.71%)
BAC  53.24
-0.22 (-0.41%)
GOOG  383.22
+1.28 (0.34%)
META  608.75
-3.16 (-0.52%)
MSFT  414.44
+6.66 (1.63%)
NVDA  198.45
-1.12 (-0.56%)
ORCL  171.83
+10.44 (6.47%)
TSLA  390.82
+9.19 (2.41%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.